Publish with Us Search
Publish with Us

Pharmaceuticals and Nanotech Connect

ISSN: 3106-4949
Volumes

SCIFINITI ALERT!

Subscribe for research updates and exclusive content straight to your inbox

Articles

 
open-access Review Article

Available Online: 16 Jun 2026

Nanoparticle-Based Vaccines: From Design and Immune Modulation to Clinical Translation

Volume 1

Journal: Pharmaceuticals and Nanotech Connect
open-access Review Article

Available Online: 06 Jun 2026

Targeting Angiogenesis in Rheumatoid Arthritis: Mechanistic Insights, Therapeutic Advances and Nanomedicine Perspectives

Volume 1

Angiogenesis is the formation of new blood vessels, a physiological process that can become dysregulated under pathological conditions, including autoimmune diseases. In rheumatoid arthritis, a prototypic autoimmune disorder characterized by chronic synovial inflammation and joint destruction, pathological angiogenesis plays a crucial role in sustaining inflammation, facilitating immune cell infiltration, and promoting pannus formation. This review synthesizes recent advances (2023–2025) in the understanding of the mechanisms driving angiogenesis in autoimmune diseases,..

Journal: Pharmaceuticals and Nanotech Connect
open-access Research Article

Available Online: 31 May 2026

Gold Nanoparticle Shape Design for Ophthalmic Imaging and Therapy

Volume 1

Journal: Pharmaceuticals and Nanotech Connect
open-access Editorial

Published: 08 Dec 2025

Emerging Nanotechnologies in Pharmaceutical Sciences: Opportunities and Challenges

Volume 1

It is my honor to serve as the Editor-in-Chief of Pharmaceuticals and Nanotech Connect, a newly established journal by Scifiniti, and to introduce its inaugural issue. Our journal provides a dynamic platform that bridges recent advancements in nanotechnology and conventional pharmaceutical sciences, fostering innovation and translational research while promoting the global integration of education, research, and practice in pharmacy and nanotechnology. The focus of this journal is to disseminate creative..

Journal: Pharmaceuticals and Nanotech Connect
open-access Editorial

Published: 08 Dec 2025

Emerging Nanotechnologies in Pharmaceutical Sciences: Opportunities and Challenges

Volume 1

It is my honor to serve as the Editor-in-Chief of Pharmaceuticals and Nanotech Connect, a newly established journal by Scifiniti, and to introduce its inaugural issue. Our journal provides a dynamic platform that bridges recent advancements in nanotechnology and conventional pharmaceutical sciences, fostering innovation and translational research while promoting the global integration of education, research, and practice in pharmacy and nanotechnology. The focus of this journal is to disseminate creative..

Journal: Pharmaceuticals and Nanotech Connect
Share
Help